Another meta-analysis of RCTs investigates the effects of pioglitazone on blood leptin levels in patients with T2DM and showed a significant difference, although relatively few RCTs are included, and a high level of statistical heterogeneity are found. Here, LEP is linked to type 2 diabetes mellitus.